(Q34137765)

31 July 2017

1 reference

title

Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors (English)

1 reference

31 July 2017

0 references

Whelton A

1

1 reference

PubMed ID

11173048

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

American Journal of Medicine

31 July 2017

1 reference

31 July 2017

110 Suppl 3A

1 reference

31 July 2017

33S-42S

1 reference

Nonsteroidal anti-inflammatory drugs: effects on kidney function

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Clinical implications of prostaglandin and thromboxane A2 formation (1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Clinical implications of prostaglandin and thromboxane A2 formation (2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Acute Oliguric Renal Failure Induced by Indomethacin: Possible Mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Ibuprofen-induced acute renal failure with acute tubular necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Nonsteroidal antiinflammatory drugs and their effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Renal syndromes associated with nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Ibuprofen induced hyponatraemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Glomerular and interstitial disease induced by nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Renal papillary necrosis due to ibuprofen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Papillary Necrosis Following Phenylbutazone Ingestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Blood pressure, stroke, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

The impact of nonsteroidal anti-inflammatory drugs on hypertension: alternative analgesics for patients at risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Nonsteroidal anti-inflammatory drugs and antihypertensives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

NSAIDs and increased blood pressure. What is the clinical significance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Nonsteroidal anti-inflammatory drugs and antihypertensives. Cooperative malfeasance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Detection and treatment of hypertension in older individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Are selective COX-2 inhibitors nephrotoxic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Acute renal failure associated with rofecoxib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Changes in renal function with aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Renal effects of nonsteroidal antiinflammatory drugs. Heightened risk to the elderly?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Effects of celecoxib and naproxen on renal function in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

The Effect of Indomethacin on Proteinuria and Kidney Function in the Nephrotic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900699-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(00)00699-9

1 reference

31 July 2017

1 reference

PubMed ID

11173048